首页 | 本学科首页   官方微博 | 高级检索  
   检索      


Vascular Endothelial Growth Factor Receptor 2 (VEGFR2) Contributes to Tamoxifen Resistance in Estrogen-Positive Breast Cancer Patients
Authors:Dronova  T A  Babyshkina  N N  Zavyalova  M V  Slonimskaya  E M  Cherdyntseva  N V
Institution:1.Cancer Research Institute, Tomsk National Research Medical Center, Russian Academy of Sciences, 634009, Tomsk, Russia
;2.National Research Tomsk State University, 634050, Tomsk, Russia
;3.Siberian State Medical University, 634050, Tomsk, Russia
;4.St. Petersburg University, 199034, St Petersburg, Russia
;
Abstract:Molecular Biology - Crosstalk between the estrogen receptors and the receptor tyrosine kinases, including vascular endothelial growth factor receptor type II (VEGFR2), is a key mechanism in breast...
Keywords:
本文献已被 SpringerLink 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号